By Sriparna Roy (Reuters) -Eli Lilly agreed to buy Morphic Holding (NASDAQ:MORF) for $3.2 billion in cash, the companies said on ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Now the question is: Is it too late to get in on this weight loss giant, or is Lilly stock still a buy? Let's find out. So, first let's talk about the Eli Lilly story so far. It's important to ...

or is Lilly stock still a buy? Let's find out. Image source: Getty Images. What's behind Lilly's double-digit revenue growth So, first let's talk about the Eli Lilly story so far. It's important ...

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other low risk ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the ...

Seeking Alpha analysts are positive and see the stock as a Buy. Most recently, Eli Lilly announced plans to more than double its recent investments in domestic medicine production to over $50B on ...

Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical company specializing in the discovery, development, and commercialization of medicines for diabetes, oncology, immunology, and neuroscience.